Your words! START TO FINISH, for you to compare possibilities for mRNA facility in Australia. Obviously, you have to purchase the facility (from Novartis Sep 20) and then deliver the final approved product (Apr 21). It could not be clearer, but you continue to argue the point.
Again, your words were "start to finish" which you have diluted ever since.
Absolutely, I have been following their progress for some time.
Mainz, Germany, Sept. 17, 2020 (GLOBE NEWSWIRE) -- Facility will become one of the largest mRNA manufacturing sites in Europe and the third site in the BioNTech manufacturing network in Germany expected to produce BNT162 for global supply Expected to be fully operational in the first half 2021 with
investors.biontech.de
September 2020, that would be your "start". You generally can't operate in a facility, that you don't have rights on.
Fairly familiar with project timelines. Purchase, build or repurpose a facility (Sep2020), purpose-build the plant (in this case, highly specialised, not 'simple' as you mentioned somewhere). Testing, approvals, production, distribution. (April 2021). And remember this is the originator company, already in production in high-tech Germany.